80 related articles for article (PubMed ID: 12006729)
1. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography.
Hartvig P; Nordberg A; Torstenson R; Sjöberg P; Fasth KJ; Långström B
Dement Geriatr Cogn Disord; 2002; 13(4):199-204. PubMed ID: 12006729
[TBL] [Abstract][Full Text] [Related]
2. Regional brain distribution and binding of the muscarinic receptor agonist CI-979 studied by positron emission tomography in the monkey.
Hartvig P; Torstenson R; Bjurling P; Fasth KJ; Längström B; Nordberg A
Dement Geriatr Cogn Disord; 1997; 8(5):259-66. PubMed ID: 9298626
[TBL] [Abstract][Full Text] [Related]
3. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
Schwarz RD; Callahan MJ; Coughenour LL; Dickerson MR; Kinsora JJ; Lipinski WJ; Raby CA; Spencer CJ; Tecle H
J Pharmacol Exp Ther; 1999 Nov; 291(2):812-22. PubMed ID: 10525104
[TBL] [Abstract][Full Text] [Related]
4. Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.
Tani Y; Ishihara T; Kanai T; Ohno T; Andersson J; Lilja A; Antoni G; Fasth KJ; Bjurling P; Westerberg G
J Neural Transm Gen Sect; 1995; 102(3):189-208. PubMed ID: 8788068
[TBL] [Abstract][Full Text] [Related]
5. Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys.
Callahan MJ
Psychopharmacology (Berl); 1999 Jun; 144(3):234-8. PubMed ID: 10435389
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography studies on some neurotransmitter receptor systems with 6R-tetrahydrobiopterin pretreatment.
Watanabe Y; Tani Y; Kanai T; Hartvig P; Inoue O; Andersson J; Lilja A; Långström B
Adv Exp Med Biol; 1993; 338():321-6. PubMed ID: 8304129
[No Abstract] [Full Text] [Related]
7. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Hartvig P; Torstenson R; Tedroff J; Watanabe Y; Fasth KJ; Bjurling P; Långström B
J Neural Transm (Vienna); 1997; 104(4-5):329-39. PubMed ID: 9295169
[TBL] [Abstract][Full Text] [Related]
9. Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease.
Trollor JN; Sachdev PS; Haindl W; Brodaty H; Wen W; Walker BM
Psychiatry Clin Neurosci; 2006 Oct; 60(5):616-25. PubMed ID: 16958947
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease.
Sedman AJ; Bockbrader H; Schwarz RD
Life Sci; 1995; 56(11-12):877-82. PubMed ID: 10188788
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
[TBL] [Abstract][Full Text] [Related]
12. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
13. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
Gronier B; Rasmussen K
Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
16. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
[TBL] [Abstract][Full Text] [Related]
17. The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.
Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
Synapse; 2013 Sep; 67(9):586-95. PubMed ID: 23504964
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice.
Gautam D; Heard TS; Cui Y; Miller G; Bloodworth L; Wess J
Mol Pharmacol; 2004 Aug; 66(2):260-7. PubMed ID: 15266016
[TBL] [Abstract][Full Text] [Related]
19. Facilitation of dopaminergic neural transmission does not affect [(11)C]SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D(1) receptors: PET studies in the conscious monkey brain.
Tsukada H; Harada N; Ohba H; Nishiyama S; Kakiuchi T
Synapse; 2001 Dec; 42(4):258-65. PubMed ID: 11746724
[TBL] [Abstract][Full Text] [Related]
20. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
